Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models.
Journal
NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070
Informations de publication
Date de publication:
2019
2019
Historique:
received:
05
07
2018
revised:
08
01
2019
accepted:
10
01
2019
pubmed:
22
1
2019
medline:
4
1
2020
entrez:
22
1
2019
Statut:
ppublish
Résumé
Relapse rates are consistently high for stimulant user disorders. In order to obtain prognostic information about individuals in treatment, machine learning models have been applied to neuroimaging and clinical data. Yet few efforts have been made to test these models in independent samples or show that they can outperform linear models. In this exploratory study, we examine whether machine learning models relative to linear models provide greater predictive accuracy and less overfitting. This longitudinal study included 63 methamphetamine-dependent (training sample) and 29 cocaine-dependent (test sample) individuals who completed an MRI scan during residential treatment. Linear and machine learning models predicting relapse at a one-year follow up that were previously developed in the methamphetamine-dependent sample using neuroimaging and clinical variables were applied to the cocaine-dependent sample. Receiver operating characteristic analysis was used to assess performance using area under the curve (AUC) as the primary outcome. Twelve individuals in the cocaine-dependent sample remained abstinent, and 17 relapsed. The linear models produced more accurate prediction in the training sample than the machine learning models but showed reduced performance in the testing sample, with AUC decreasing by 0.18. The machine learning models produced similar predictive performance in the training and test samples, with AUC changing by 0.03. In the test sample, neither the linear nor the machine learning model predicted relapse at rates above chance. Although machine learning algorithms may have advantages, in this study neither model's performance was sufficient to be clinically useful. In order to improve predictive models, stronger predictor variables and larger samples are needed.
Identifiants
pubmed: 30665102
pii: S2213-1582(19)30026-9
doi: 10.1016/j.nicl.2019.101676
pmc: PMC6350259
pii:
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
101676Subventions
Organisme : NIDA NIH HHS
ID : R01 DA016663
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA027797
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA024778
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA013525
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018307
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH113708
Pays : United States
Organisme : NIAAA NIH HHS
ID : F31 AA027169
Pays : United States
Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.